Is metabolic syndrome X an inflammatory condition?

Experimental Biology and Medicine

Volumn 227, Issue 11, 2002, Pages 989-997

  Das, Undurti N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

Adiponectin; Diabetes mellitus; Hypertension; Inflammation; Insulin resistance; Metabolic syndrome X; Obesity; Perinatal nutrition; Polyunsaturated fatty acids

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ADIPONECTIN; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CYTOKINE; DOPAMINE; FIBRINOGEN; INSULIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE Y; NEUROTRANSMITTER; NITRIC OXIDE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYUNSATURATED FATTY ACID; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL MODEL; ATHEROSCLEROSIS; CHILD; DIABETES MELLITUS; EXERCISE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LOW BIRTH WEIGHT; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; PREVALENCE; SHORT SURVEY;

ANIMALIA;

EID: 0036908984     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222701106     Document Type: Short Survey

References (99)

1. Hansen BC. The metabolic syndrome X. Ann NY Acad Sci 892:1-24, 1999.
2. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
3. Ortmeyer HK, Bodkin NL, Hansen BC. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol 265:R552-R558, 1993.
4. Pravenec M, Zidek V, Simakova M, Kren V, Krenova D, Horky K, Jachymova M, Mikova B, Kazdova L, Aitman TJ, Churchill PC, Webb RC, Hingarh NH, Yang Y, Wang JM, Lezin EM, Kurtz TW. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest 103:1651-1657, 1999.
5. DuClos TW. Function of C-reactive protein. Ann Med 32:274-278, 2000.
6. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease): Augsburg cohort study, 1984 to 1992. Circulation 99:237-242, 1999.
7. Mendell MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: A population based cross-sectional study. Br Med J 312:1061-1065, 1996.
8. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 282:2131-2135, 1999.
9. Visser M, Bouter LM, McQuillan GM, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 107:1-6, 2001.
10. Crichton MB, Nichols JE, Zhao Y, Bulun SE, Simpson ER. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol 118:215-220, 1996.
11. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Loppack SW. Subcutaneous adipose tissue release interleukin-6, but not tumor necrosis factor-3, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997.
12. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850, 1998.
13. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99:2221-2222, 1999.
14. Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE. Testosterone and IL-6 requirements for human Creactive protein gene expression in transgenic mice. J Immunol 160:5294-5299, 1998.
15. 1c levels in healthy women. Int J Obesity 24:1207-1211, 2000.
16. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obesity 24:1392-1395, 2000.
17. Chu N-F, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obesity 24:1085-1092, 2000.
18. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 12:57-65, 1998.
19. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ. Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A 96:7047-7052, 1999.
20. Das UN. Is obesity an inflammatory condition? Nutrition 17:953-966, 2001.
21. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462, 2000.
22. Xu Z, Tong C, Eisenach JC. Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology 85:107-111, 1996.
23. Cho L, Tsunoda M, Sharma RP. Effects of endotoxin and tumor necrosis factor-α on regional brain neurotransmitters in mice. Nat Toxins 7:187-195, 1999.
24. Venters HD, Dantzer R, Kelley KW. A new concept in neurodegeneration: TNF-α is a silencer of survival signals. Trends Neurosci 23:175-180, 2000.
25. Liang Y, Luo S, Cincotta AH. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet cell function. Metabolism 48:1287-1289, 1999.
26. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJP. Catch-up growth in childhood and death from coronary heart disease: Longitudinal study. Br Med J 318:427-431, 1999.
27. von Kries R, Kolletzko B, Sauerwald T, von Mutius E. Does breastfeeding protect against childhood obesity? Adv Exp Med Biol 478:29-39, 2000.
28. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W. Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care 23:1835-1839, 2000.
29. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000.
30. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126, 1999.
31. Huber SA, Sakkinen P, Conza D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19:2364-2367, 1999.
32. Braunwald E. Shattuck Lecture: Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369, 1997.
33. Ridker PM, Buring JE, Shih H, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998.
34. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000.
35. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343:1139-1147, 2000.
36. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP, Lamarche B. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Int Med 161:2474-2480, 2001.
37. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease. J Am Med Assoc 286:2107-2113, 2001.
38. Zhang R, Brennan M-L, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. J Am Med Assoc 286:2136-2142, 2001.
39. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997.
40. Vane JR. The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs 33(Suppl 1):18-27, 1987.
41. Kannel WB, Wolf PA, Garrison RJ. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Bethesda, MD: National Heart, Lung, and Blood Institute, 1987. (NIH publication no. 87-2703).
42. Webber LS, Voors AW, Srinivasan SR, Frerichs RR, Berenson GS. Occurrence in children of multiple risk factors for coronary artery disease: The Bogalusa Heart Study. Prev Med 8:407-418, 1979.
43. Khoury P, Morrison JA, Kelly K, Mellies M, Horvitz R, Glueck CJ. Clustering and interrelationships of coronary heart disease risk factors in school children, ages 6-19. Am J Epidemiol 112:524-538, 1980.
44. Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults: The Bogalusa Heart Study. Am J Epidemiol 125:364-372, 1987.
45. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Int Med 154:1842-1847, 1994.
46. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338:1650-1656, 1998.
47. Whincup PH, Gilg JA, Papacosta O, Seymour C, Miller GJ, Alberti KGMM, Cook DG. Early evidence of ethnic difference in cardiovascular risk: Cross sectional comparison of British South Asian and white children. BMJ 324:1-6, 2002.
48. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly influenced by maternal hypercholesterolemia. J Clin Invest 100:2680-2690, 1997.
49. Naopli C, Glass CK, Wiztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypecholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of early lesions in children (FELIC) study. Lancet 354:1234-1241, 1999.
50. Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: Clinical and pathologic implications. Eur Heart J 22:4-9, 2001.
51. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and secretion. Obes Res 9:414-417, 2001.
52. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, Pepys MB, Kooner JS. C-reactive protein, insulin resistance, central obesity, and coronary disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104:145-150, 2001.
53. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 286:327-334, 2001.
54. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 50:2384-2389, 2001.
55. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol 281:E1137-E1143, 2001.
56. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 276:42077-42083, 2001.
57. Hotamisligil GS. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 245:621-625, 1999.
58. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159, 2001.
59. Dovio A, Angeli A. Cytokines and type 2 diabetes mellitus. J Am Med Assoc 286:2233, 2001.
60. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 38:399-403, 2001.
61. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW. Plasma concentrations of C-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke 32:2575-2579, 2001.
62. Taubes G. Does inflammation cut to the heart of the matter? Science 296:242-245, 2002.
63. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): Relation to reduced fetal growth. Diabetologia 36:62-67, 1993.
64. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. Br Med J 319:245-249, 1999.
65. Whincup PH, Cook DG, Adshead FA, Taylor S, Walker M, Papacosta O, Alberti KG. Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11 year-old children. Diabetologia 40:319-326, 1997.
66. Bodkin NL, Ortmeyer HK, Hansen BC. Long-term dietary restriction in older-aged rhesus monkeys: Effects on insulin resistance. J Gerotol Biol Sci 50:B142-B147, 1995.
67. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001.
68. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790-797, 2001.
69. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of ischemic heart disease. J Am Med Assoc 281:1722-1727, 1999.
70. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189:1699-1706, 1999.
71. Das UN. Free radicals, cytokines, and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 215:145-152, 2000.
72. Clapp JF, Kiess W. Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor-α and leptin. Am J Obstet Gynecol 182:300-306, 2000.
73. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hanique B. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338-3342, 2000.
74. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli. Circulation Res 89:709-715, 2001.
75. Hoffmann J, Haendeler J, Zeiher AM, Dimmeler S. TNFα and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem 276:41383-41387, 2001.
76. Meilhac O, Ramachandran S, Chiang K, Santanam N, Parthasarathy S. Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Arterioscler Thromb Vasc Biol 21:1681-1688, 2001.
77. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138-1143, 2001.
78. Das UN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essen Fatty Acids.
79. Fall CHD, Barker DJP, Osmond C, Winter PD, Clark PMS, Hales CN. Relation of infant feeding to adult serum cholesterol concentration and death from ischemic heart disease. Br Med J 304:801-805, 1992.
80. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in South Asians overseas-a review. J Clin Epidemiol 42:597-609, 1989.
81. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk of South Asians. Lancet 337:382-386, 1991.
82. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 17:337-346, 2001.
83. Huang Y-J, Fang VS, Chou Y-C, Kwok C-F, Ho L-T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 46:1252-1258, 1997.
84. Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 46:1458-1464, 1997.
85. Nobukata H, Ishikawa T, Obata M, Shibutani Y. Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism 49:912-919, 2000.
86. Storlien LH, Pan DA, Kriketos AD, O'Connor J, Caterson ID, Cooney GJ, Jenkins AB, Baur LA. Skeletal muscle membrane lipids and insulin resistance. Lipids 31(Suppl):S261-S265, 1996.
87. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Cambell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328:238-244, 1993.
88. Clifton PM, Nestel PJ. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot Essen Fatty Acids 59:191-194, 1998.
89. Barker DJP. Fetal and Infant Origins of Adult Disease. London: BMJ Publishing, 1992.
90. Ozanne SE, Martensz ND, Petry CJ, Hales CN. Maternal low protein diet in rats programs fatty acid desaturase activities in the offspring. Diabetologia 41:1337-1342, 1998.
91. Mercuri O, de Tomas E, Itarte H. Prenatal protein depletion and (δ9, δ6, and δ5 desaturases in the rat. Lipids 14:822-825, 1979.
92. Dhalgren J, Nilsson C, Jennische E, Ho H-P, Eriksson E, Niklasson A, Bjorntorp P, Wikland KA, Holmang A, Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol 281:E326-E334, 2001.
93. Reseland JE, Haugen F, Hollung K. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42:743-750, 2001.
94. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of corresponding Nacylethanolamines in piglets. Proc Natl Acad Sci U S A 98:6402-6406, 2001.
95. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kanos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825, 2001.
96. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARγ figands increase expression and plasma concentrations of adiponectin, an adiposederived protein. Diabetes 50:2094-2099, 2001.
97. Febbraio M, Hajjar DP, Silverstein RL. CD36: A class of scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791, 2001.
98. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001.
99. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease. J Am Med Assoc 286:1187-1194, 2001.